Portfolio Update

3 January 2007

                  FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC                  
                                (the "Company")                                

                      QUARTERLY STATEMENT OF INVESTMENTS                       

In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:

  * Investments valuing greater than 5% of the Company's gross assets comprise
    the following:
   
Company Name                                        Value of       % of Total  
                                                 Investment at      Portfolio  
                                                31 December 2006      Assets    
                                                                               
NOVARTIS CHF0.50 REGD                              29,237,144         9.27     
PFIZER INC COM USD0.05                             21,059,643         6.68     
GENENTECH INC COM STK USD0.02 NPV                  20,292,006         6.43     
WYETH COM USD0.333                                 18,498,940         5.87     
AMGEN COM USD0.0001                                17,231,509         5.46     
JOHNSON & JOHNSON COM USD1                         16,369,272         5.19     

  * The ten largest investments held by the Company comprise the following:
   
Company Name                                  Value of Investment   % of Total 
                                              at 31 December 2006    Portfolio  
                                                                      Assets   
                                                                              
NOVARTIS CHF0.50 REGD                              29,237,144          9.27    
PFIZER INC COM USD0.05                             21,059,643          6.68    
GENENTECH INC COM STK USD0.02 NPV                  20,292,006          6.43    
WYETH COM USD0.333                                 18,498,940          5.87    
AMGEN COM USD0.0001                                17,231,509          5.46    
JOHNSON & JOHNSON COM USD1                         16,369,272          5.19    
SCHERING-PLOUGH CORPORATION COM USD0.50            13,782,306          4.37    
TAKEDA PHARAMACEUTICAL CO NPV                      13,663,130          4.33    
GEN-PROBE INC USD0.0001                            13,099,047          4.15    
MEDIMMUNE INC COM USD0.01                          11,372,046          3.61    

                                 
For further information please contact:
Tracey Lago, Senior Company Secretary
Close Investments Limited

Telephone: [phone]